Imminent Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Bangalore South, Karnataka, India, established in 2023.
2023 Bangalore South, Karnataka, India Active
Last Updated:
About Imminent Pharmaceutical Private Limited

Imminent Pharmaceutical Private Limited, a active private limited company, was established on 07 August 2023 in Bangalore South, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U82920KA2023PTC176993. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.

Its leadership includes Sharmistha Banerjee Sarkar (Director), Gopal Sutradhar (Director). Past directors included Piyali Das. It is based at C/O Pradeep S Surianaraya, V Sy No 2/2 Kasavanahalli, Bangalore South, Karnataka, 560035.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U82920KA2023PTC176993

  • Registration Number

    176993

  • Incorporation Date

    07 August 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.40 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.40 M
  • Company Age 2 Year, 6 Months
Company report

Imminent Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Imminent Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Imminent Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Sharmistha Banerjee Sarkar Director 07 Aug 2023 Current
Gopal Sutradhar Director 07 Aug 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Jun 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Imminent Pharmaceutical.

Enhance accessibility to Imminent Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Imminent Pharmaceutical revenue growth over time
Imminent Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Imminent Pharmaceutical?

Unlock access to Imminent Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Imminent Pharmaceutical?

Unlock and access historical data on people associated with Imminent Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Imminent Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imminent Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Imminent Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Progress on Sharmistha Banerjee Sarkar was appointed as a Director was appointed as a Director on 07 Aug 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Director Appointment

    The activity Gopal Sutradhar was appointed as a Director was appointed as a Director on 07 Aug 2023 & has been associated with this company since 2 years 6 months . was completed.

  • Company Incorporation

    Progress on Imminent Pharmaceutical Private Limited was registered on 07 Aug 2023 with Roc Bangalore & aged 2 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Imminent Pharmaceutical Private Limited?

The CIN of Imminent Pharmaceutical Private Limited is U82920KA2023PTC176993.

Where is Imminent Pharmaceutical Private Limited headquartered?

Imminent Pharmaceutical Private Limited is headquartered at C/O Pradeep S Surianaraya, V Sy No 2/2 Kasavanahalli, Bangalore South, Karnataka, 560035.

When was Imminent Pharmaceutical Private Limited incorporated?

Imminent Pharmaceutical Private Limited was incorporated on 07 August 2023.

Who are the current directors of Imminent Pharmaceutical Private Limited?

The current directors of Imminent Pharmaceutical Private Limited are

What is the primary industry of Imminent Pharmaceutical Private Limited?

The primary industry of Imminent Pharmaceutical Private Limited is Pharma.

Is Imminent Pharmaceutical Private Limited a listed company?

Imminent Pharmaceutical Private Limited is unlisted.

What is the capital structure of Imminent Pharmaceutical Private Limited?

The authorized capital of Imminent Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available